Cargando…
Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
Over the past 20 years, there has been a drastically increased understanding of the genetic basis of Amyotrophic Lateral Sclerosis. Despite the identification of more than 40 different ALS-causing mutations, the accumulation of neurotoxic misfolded proteins, inclusions, and aggregates within motor n...
Autores principales: | Amin, Azin, Perera, Nirma D., Beart, Philip M., Turner, Bradley J., Shabanpoor, Fazel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694295/ https://www.ncbi.nlm.nih.gov/pubmed/33158177 http://dx.doi.org/10.3390/cells9112413 |
Ejemplares similares
-
Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression
por: Perera, Nirma D., et al.
Publicado: (2017) -
The Amyotrophic Lateral Sclerosis M114T PFN1 Mutation Deregulates Alternative Autophagy Pathways and Mitochondrial Homeostasis
por: Teyssou, Elisa, et al.
Publicado: (2022) -
Metabolic Dysfunction in Motor Neuron Disease: Shedding Light through the Lens of Autophagy
por: De Silva, Subhavi, et al.
Publicado: (2022) -
Modular Synthesis of Trifunctional Peptide-oligonucleotide Conjugates via Native Chemical Ligation
por: Dastpeyman, Mohadeseh, et al.
Publicado: (2021) -
Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019)